SCHEMBL5651328

SCHEMBL5651328

O=C(O)N(CNCc1ccc2c(c1)OCCO2)N1CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALKBH5 Q6P6C2 1/20 0.48
FTO Q9C0B1 1/20 0.48
DPP7 Q9UHL4 2/20 0.44
ALDH1A1 P00352 7/20 0.44
KDM4E B2RXH2 2/20 0.43
HPGD P15428 3/20 0.42
TSHR P16473 2/20 0.42
RECQL P46063 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
FAAH O00519 1/20 0.41
USP2 O75604 1/20 0.41
MAPT P10636 1/20 0.40
HSD17B10 Q99714 1/20 0.40
HDAC1 Q13547 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5650660 0.84 ALKBH5 (0.43) ALKBH5FTODPP7ALDH1A1HPGD
SCHEMBL5650800 0.83 ALKBH5 (0.47) ALKBH5FTODPP7ALDH1A1KDM4E
SCHEMBL5651335 0.82 ALKBH5 (0.48) ALKBH5FTODPP7ALDH1A1KDM4E
SCHEMBL3687148 0.75 NPY5R (0.47) ALDH1A1KDM4EHPGDTSHRMEN1
SCHEMBL3687207 0.73 ALKBH5 (0.61) ALKBH5FTODPP7ALDH1A1KDM4E
SCHEMBL9120468 0.73 KDM4E (0.56) DPP7ALDH1A1KDM4EHPGDTSHR
SCHEMBL3689303 0.71 KDM4E (0.49) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL3698292 0.70 ALKBH5 (0.53) ALKBH5FTODPP7ALDH1A1HPGD
SCHEMBL2937839 0.70 ALDH1A1 (0.65) ALDH1A1HPGDRECQLMEN1KMT2A
SCHEMBL3691553 0.69 KDM1A (0.45) ALDH1A1HPGDTSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7223776-B2 Compounds with anti-bacterial activity MORPHOCHEM AG (DE) 2007-05-29 US disclosed
US-20060040949-A1 Novel compounds with antibacterial activity MORPHOCHEM AG 2006-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060040949-A1 Novel compounds with antibacterial activity MRPL21, Q6ZSR9, MRPL19 ALKBH5 2802/4885FTO 4747/4885DPP7 342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.